Stanford Universityと東京大学松尾研究所からヘルスケアxAIの分野で研究に取り組んでいるゲストスピーカーをお招きします。ヘルスケア領域でのAIの活用に関する研究や社会実装についてお話しいただきます。また、ヘルスケア分野に取り組むスタートアップピッチも行います。

開催日時：2025年12月9日（火）16:00~19:30
会場：Playground

(Plug and Play Japanオフィス : 東京都渋谷区道玄坂1-10-8 渋谷道玄坂東急ビル1F)

定員：100名 （オンライン配信はございません）

参加対象：
企業/スタートアップにお勤めの方、経営者の方、研究者の方、学生の方などヘルスケア領域のイノベーションやAI研究など本テーマに関心がある方であれば、どなたでも無料でご参加可能です。

We will be hosting guest speakers from Stanford University and the Matsuo Laboratory at the University of Tokyo, who are conducting research in the field of Healthcare × AI. They will share insights on AI applications in healthcare, including both research and real-world implementation. Additionally, there will be startup pitches from companies working in the healthcare sector.

Event Date & Time: Tuesday, December 8, 2025 | 16:00 – 19:30

Venue: Playground (Plug and Play Japan Office: Shibuya Dogenzaka Tokyu Building 1F, 1-10-8 Dogenzaka, Shibuya-ku, Tokyo)

Capacity: 100 participants (No online streaming available)

Who Can Attend: The event is free for anyone interested in healthcare innovation or AI research, including corporate, startup, executives, researchers, and students.

■登壇社情報

・Dr. Ethan Goh

Executive Director, Stanford ARISE Network (arise.stanford.edu)

BIO:

Dr. Ethan Goh is a healthcare executive and physician scientist with a background in clinical AI research, product development, and commercial strategy.

At Stanford, he leads multi-institutional evaluation and implementation of Large Language Model applications within healthcare, with publications in Nature Medicine and JAMA Network. His research is supported by the Macy Foundation and the Gordon & Betty Moore Foundation, and has been covered in The New York Times, The Washington Post, and CNN.

Dr. Goh is a Founding Editorial Board member and Associate Editor at BMJ Digital Health & AI. He serves as an external reviewer for digital health research funding programs. He also contributes as a keynote speaker and co-chair at academic and industry conferences—including HIMSS, the Stanford AIMI Symposium, and AMIA.

As a technology consultant and venture capital advisor, he has collaborated with Google, OpenAI, Roche, and Samsung to develop, validate, and scale AI-driven healthcare solutions.

Prior to academia, Dr. Goh practiced Internal Medicine and founded a digital health Q&A startup that provided expert medical answers to millions of users. He later served in formal roles within the NHS and the Ministry of Health, where he helped shape national health policy and regulatory frameworks.

Dr Goh holds a medical degree from Imperial College London, and a Masters in Clinical Informatics and Management from Stanford University.

・Dr. Tadahisa Kagimoto

BIO:

2011年2月、難治性疾患に苦しむ患者さんへ治癒と希望を届ける、という初心の実現に向け、再生・細胞医薬品という新たな産業創生を目指しヘリオスを設立しました。2012年2月、ヘリオス代表に就任、2015年6月、東証マザーズ上場し、日本と米国のオフィスで140名を超える現在の規模にまで会社を成長さています。当社は、再生医療に対する日本の先進的な規制の枠組みを活用して、開発を行っています。現在は、骨髄由来の体性幹細胞製品を用いた脳梗塞急性期及び急性呼吸窮迫症候群の治療法開発を目指し、国内で２つの治験を実施中です。同時に、当社独自のユニバーサルドナーiPS細胞プラットフォームを活用して、がん免疫、眼科、臓器原基の分野で次世代パイプラインの研究・開発を行っています。「『生きる』を増やす。爆発的に。」というミッションのもと、iPS細胞等の幹細胞技術を用いたプラットフォーム技術を確立し、新たな治療法の開発を目指しています。

鍵本は、九州大学病院にて眼科医として勤務後2005年、九州大学発のバイオ技術の実用化を目指したアキュメンバイオファーマ（株）（現アキュメン（株））を設立しています。BBG250を利用した眼科手術補助剤は、パートナー企業とともに欧州にて承認取得・上市を果たし、デファクトスタンダードの地位を獲得しています。

・Akane Ichiki

BIO:

After graduating from the State University of New York, Akane worked as a researcher at Kyoto University’s Center for iPS Cell Research and Application, conducting regenerative medicine studies using genome editing technologies. My work focused on developing cell therapies for muscular dystrophy patients, with results published in Stem Cell Reports. I later completed my graduate studies at the School of Life Science and Technology, Tokyo Institute of Technology. I have contributed to interdisciplinary projects at five research institutions, ranging from physical chemistry to molecular and cell biology, and co-authored over ten academic papers. Having witnessed the barriers between research outcomes and their practical application in drug discovery and regenerative medicine, I joined Plug and Play’s Health division in 2025, where I focus on building new frameworks to deliver science to society by connecting bio-startups with industry.

——————-

Privacy Policyに同意の上ご参加ください：https://japan.plugandplaytechcenter.com/privacy-policy/お問い合わせ：メール（担当者名）